Suppr超能文献

补体调节:生理学及与疾病的相关性

Complement regulation: physiology and disease relevance.

作者信息

Cho Heeyeon

机构信息

Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Korean J Pediatr. 2015 Jul;58(7):239-44. doi: 10.3345/kjp.2015.58.7.239. Epub 2015 Jul 22.

Abstract

The complement system is part of the innate immune response and as such defends against invading pathogens, removes immune complexes and damaged self-cells, aids organ regeneration, confers neuroprotection, and engages with the adaptive immune response via T and B cells. Complement activation can either benefit or harm the host organism; thus, the complement system must maintain a balance between activation on foreign or modified self surfaces and inhibition on intact host cells. Complement regulators are essential for maintaining this balance and are classified as soluble regulators, such as factor H, and membrane-bound regulators. Defective complement regulators can damage the host cell and result in the accumulation of immunological debris. Moreover, defective regulators are associated with several autoimmune diseases such as atypical hemolytic uremic syndrome, dense deposit disease, age-related macular degeneration, and systemic lupus erythematosus. Therefore, understanding the molecular mechanisms by which the complement system is regulated is important for the development of novel therapies for complement-associated diseases.

摘要

补体系统是固有免疫反应的一部分,因此可抵御入侵病原体、清除免疫复合物和受损的自身细胞、促进器官再生、提供神经保护,并通过T细胞和B细胞参与适应性免疫反应。补体激活对宿主生物体可能有益也可能有害;因此,补体系统必须在外源或修饰的自身表面激活与完整宿主细胞抑制之间保持平衡。补体调节蛋白对于维持这种平衡至关重要,可分为可溶性调节蛋白,如H因子,以及膜结合调节蛋白。有缺陷的补体调节蛋白会损害宿主细胞并导致免疫碎片的积累。此外,有缺陷的调节蛋白与几种自身免疫性疾病有关,如非典型溶血性尿毒症综合征、致密物沉积病、年龄相关性黄斑变性和系统性红斑狼疮。因此,了解补体系统的调节分子机制对于开发针对补体相关疾病的新疗法很重要。

相似文献

1
Complement regulation: physiology and disease relevance.
Korean J Pediatr. 2015 Jul;58(7):239-44. doi: 10.3345/kjp.2015.58.7.239. Epub 2015 Jul 22.
3
Complement and immune defense: from innate immunity to human diseases.
Immunol Lett. 2009 Sep 22;126(1-2):1-7. doi: 10.1016/j.imlet.2009.07.005. Epub 2009 Jul 17.
4
Complement System Part II: Role in Immunity.
Front Immunol. 2015 May 26;6:257. doi: 10.3389/fimmu.2015.00257. eCollection 2015.
6
The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci.
Vaccine. 2008 Dec 30;26 Suppl 8:I67-74. doi: 10.1016/j.vaccine.2008.11.015.
7
Potential influences of complement factor H in autoimmune inflammatory and thrombotic disorders.
Mol Immunol. 2017 Apr;84:84-106. doi: 10.1016/j.molimm.2017.01.015. Epub 2017 Feb 16.
8
Complement factor H related proteins in immune diseases.
Vaccine. 2008 Dec 30;26 Suppl 8:I9-14. doi: 10.1016/j.vaccine.2008.11.021.
9
[The role of complement in physiology and pathology].
Postepy Hig Med Dosw (Online). 2007;61:167-77.
10
The role of complement in C3 glomerulopathy.
Mol Immunol. 2015 Sep;67(1):21-30. doi: 10.1016/j.molimm.2015.03.012. Epub 2015 Apr 28.

引用本文的文献

1
CD55 upregulation in T cells of COVID-19 patients suppresses type-I interferon responses.
Commun Biol. 2025 May 2;8(1):690. doi: 10.1038/s42003-025-08066-z.
2
Candidiasis: Insights into Virulence Factors, Complement Evasion and Antifungal Drug Resistance.
Microorganisms. 2025 Jan 25;13(2):272. doi: 10.3390/microorganisms13020272.
4
Gene therapy for geographic atrophy in age-related macular degeneration: current insights.
Eye (Lond). 2025 Feb;39(2):274-283. doi: 10.1038/s41433-024-03463-w. Epub 2024 Nov 22.
5
"Izervay (avacincaptad pegol): paving the way for vision preservation in geographic atrophy".
Ann Med Surg (Lond). 2024 Apr 3;86(5):2413-2416. doi: 10.1097/MS9.0000000000002021. eCollection 2024 May.
6
The complement cascade in lung injury and disease.
Respir Res. 2024 Jan 4;25(1):20. doi: 10.1186/s12931-023-02657-2.
7
Genetic bases of C7 deficiency: systematic review and report of a novel deletion determining functional hemizygosity.
Front Immunol. 2023 May 25;14:1192690. doi: 10.3389/fimmu.2023.1192690. eCollection 2023.
8
Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration.
Clin Ophthalmol. 2023 Jan 23;17:321-327. doi: 10.2147/OPTH.S367089. eCollection 2023.
9
Coordinated local RNA overexpression of complement induced by interferon gamma in myositis.
Sci Rep. 2023 Feb 4;13(1):2038. doi: 10.1038/s41598-023-28838-z.
10
New Insights into the Role of the Complement System in Human Viral Diseases.
Biomolecules. 2022 Jan 28;12(2):226. doi: 10.3390/biom12020226.

本文引用的文献

1
Intravitreal human complement factor H in a rat model of laser-induced choroidal neovascularisation.
Br J Ophthalmol. 2013 Mar;97(3):367-70. doi: 10.1136/bjophthalmol-2012-302307. Epub 2012 Dec 19.
2
Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.
J Am Soc Nephrol. 2013 Jan;24(1):53-65. doi: 10.1681/ASN.2012060570. Epub 2012 Nov 30.
4
Complement in glomerular disease.
Adv Chronic Kidney Dis. 2012 Mar;19(2):84-92. doi: 10.1053/j.ackd.2012.02.015.
5
Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings.
Pediatr Nephrol. 2011 Nov;26(11):2085-8. doi: 10.1007/s00467-011-1989-4. Epub 2011 Aug 30.
6
Complement and glomerular disease: new insights.
Curr Opin Nephrol Hypertens. 2011 May;20(3):271-7. doi: 10.1097/MNH.0b013e328345848b.
7
Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.
Clin J Am Soc Nephrol. 2011 May;6(5):1009-17. doi: 10.2215/CJN.07110810. Epub 2011 Mar 17.
8
9
Complement factor H deficiency accelerates development of lupus nephritis.
J Am Soc Nephrol. 2011 Feb;22(2):285-95. doi: 10.1681/ASN.2010060647. Epub 2010 Dec 9.
10
Production of biologically active complement factor H in therapeutically useful quantities.
Protein Expr Purif. 2011 Apr;76(2):254-63. doi: 10.1016/j.pep.2010.12.002. Epub 2010 Dec 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验